ResMed (RMD) Form 144: Proposed sale of 487 shares, $121,871

ResMed (RMD) received a Form 144 notice for a proposed sale of 487 common shares, with an aggregate market value of $121,871.75.

Rhea-AI Filing Summary

ResMed (RMD) received a Form 144 notice for a proposed sale of 487 common shares, with an aggregate market value of $121,871.75. The approximate sale date is 11/11/2025 on the NYSE through Fidelity Brokerage Services.

The shares were acquired via restricted stock vesting on 11/11/2025 as compensation. Shares outstanding were 145,966,294 as of the filing; this is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ResMed (RMD)’s Form 144 disclose?

A proposed sale of 487 common shares with an aggregate market value of $121,871.75.

When is the proposed sale date for RMD shares?

The approximate sale date is 11/11/2025.

Which broker is listed for this Form 144 sale for RMD?

The broker is Fidelity Brokerage Services LLC.

How were the RMD shares acquired?

Through restricted stock vesting on 11/11/2025 as compensation.

On which exchange are the RMD shares to be sold?

The notice lists the NYSE.

How many ResMed shares were outstanding?

Shares outstanding were 145,966,294 as referenced in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 06:44 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001776929
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	De Witte Jan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	487	121871.75	145966294	11/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2025	Restricted Stock Vesting	Issuer			487	11/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/12/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jan De Witte
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)